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Abstract. We have previously described the isolation
of a mutant KB cell (Cyt 1 mutant) resistant to the
cytotoxic effect of cytochalasin B (CB). The Cyt 1
mutant carries an altered form of 0-actin (ß'-actin) and
lacks normal 0-actin (Toyama, S., and S. Toyama.
1984 . Cell. 37:609-614) . Increased resistance of the
Cyt 1 mutant to CB in vivo is reflected in altered prop-
erties of ß'-actin in vitro (Toyama, S., and S. Toyama.
1988. J. Cell Biol. 107:1499-1504). Here, we show
that the mutation in 0-actin is solely responsible for
the cytochalasin-resistant phenotype of the Cyt mu-
tant. We have isolated a cDNA clone encoding ß'-actin
C
ARTER (1967) first reported the effect of cytochalasins
on cell motility processes, such as inhibition of cell
movement, prevention of cytoplasmic cleavage, and
extrusion of nucleus. Since then, cytochalasins have been
widely used as a tool to study motility-related processes in
a variety of cell types (for review see Tannenbaum, 1978),
and cytochalasin sensitivity has often been taken as an indi-
cation of the involvement of an actin-based microfilament
system in the absence ofproof. In vitro studies using purified
actin have clearly indicated that cytochalasins bind one end
of actin filaments (Brown and Spudich, 1979; Flanagan and
Lin, 1980; Lin et al., 1980) and inhibit its polymerization
(Brenner and Korn, 1979 ; Brown and Spudich, 1979; Flana-
gan and Lin, 1980; Lin et al ., 1980; MacLean-Fletcher and
Pollard, 1980) by reducing the rate of monomer addition to
the barbed end ofgrowing filaments (MacLean-Fletcher and
Pollard, 1980; Lin et al., 1980; Brown and Spudich, 1981;
Pollard and Mooseker, 1981; Mabuchi, 1983; Bonder and
Mooseker, 1986). Recently, Goddette and Frieden (1985,
1986a,ó) examined the interaction of monomeric actin with
cytochalasin D to explain the finding that cytochalasin B
(CB)' accelerates the initial rate of polymerization while
reducing the final extent (L6w and Dancker, 1976). They
found that cytochalasin D binds actin monomer and induces
1. Abbreviations used in this paper: CB, cytochalasin B; tk, thymidine
kinase.
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from Cyt 1 cells. Sequence analysis reveals two muta-
tions in the coding region that substitute two amino
acid residues (Val139 --" Met and Ala295 -" Asp) . Expres-
sion of the ß'-actin cDNA confers cytochalasin resis-
tance upon transformed cytochalasin-sensitive KB cells.
Levels of resistance to CB in the transformed cell
clones correlate well with amounts of ß'-actin polypep-
tide. Both of the two mutations in ß'-actin are neces-
sary for the high level expression of cytochalasin resis-
tance. Overall, we conclude that the primary site of
action of cytochalasin on cell motility processes in
vivo is actin.
dimer formation, and proposed a mechanism which explains
both the enhanced rate of polymerization and the increased
critical concentration. The mechanism depends on the cyto-
chalasin-induced formation of dimer (to enhance the rate)
and on the cytochalasin-enhanced rate of ATP hydrolysis in
the dimer to yield higher concentrations ofmonomeric actin
containing ADP (to increase the critical concentration). Al-
though these results suggest that cytochalasins affect cell mo-
tility processes by interacting with cytoplasmic actin, the
possibility that cytochalasins have target(s) other than actin
cannot be totally excluded (for review see Cooper, 1987).
We have isolated a mutant of KB cells (Cyt 1 cells) resis-
tant to CB under the assumption that if CB interacts with cy-
toplasmic actin, then some of the drug-resistant mutants
should contain alterations in cytoplasmic actin (Toyama and
Toyama, 1984). The Cyt 1 cells carry an altered form of
0-actin (ß'-actin) and lack normal 0-actin. The alteration in
ß'-actin is not the result of a posttranslational modification.
Furthermore, increased resistance of Cyt 1 cells to CB is
reflected in altered properties of ß'-actin itself (Toyama and
Toyama, 1988) . These results strongly suggestthat the muta-
tion of /3'-actin is responsible for the cytochalasin resistance
of Cyt 1 cells, but left unanswered the question of whether
Cyt 1 cells might have mutation(s) in molecules other than
0-actin which could account for the cytochalasin resistance.
Here, we present evidence that the expression of ,ß'-actin
cDNA in cytochalasin-sensitive parental KB cellsconfers re-
sistance to CB, and conclude therefore that the primary site
of action of cytochalasin on cell motility processes is actin.
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Cell LineandCell Culture
The KB100 and KB100 Cyt 1 cell lines used in this study have been de-
scribed (Toyama et al ., 1977; Toyama and Toyama, 1984) . Cells were rou-
tinely maintained in monolayers at 37°C inMEM supplemented with 10%
newborn calf serum and 50 pg/ml kanamycin . The thymidine kinase
(tk)-deficient KB cell line (KB100TK-) was isolated from KB100 cells by
the stepwise treatment of 5-bromodeoxyuridine (Toyama, S., unpublished
results) .
CloningandSequencing off3'- andr ActincDNAs
cDNA was synthesized with oligo-dT primer from 5 ug/nil of poly(A)'
mRNA isolated from Cyt 1 cells using thecDNA synthesis kit from Phar-
macia Fine Chemicals, (Pharmacia JapanInc ., Tokyo) . Afteradding EcoRl
adaptors, cDNA was ligated intoW0 and packaged in vitro (Gigapack II
Plus; Strategene Cloning Systems, Inc ., La Jolla, CA) . cDNA clones con-
taining ß'- and -y-actin sequences were identified by plaque hybridization
using digoxigenin-labeled humancDNA clone previously shown to encode
0-actin (Hanukoglu et al ., 1983) . The digoxigenin labeling and detection
of digoxigenin-labeled probe were carried out by using the nonradioactive
DNA labeling anddetectionkit(Boehringer Mannheim GmbH, Mannheim,
Germany) . cDNAs were then subcloned into Bluescript II plasmid (Strata-
geneCloning Systems, Inc.) . Nested sets of deletions were made by exonu-
clease III digestion, and the cDNAs were sequenced by the dideoxy chain
termination method (Sanger et al ., 1977) .
Construction ofExpression Vector
Standard techniques were used for construction of the expression vector
(Maniatis et al ., 1982) . The plasmidpTKSVO'-act 1 is shown in Fig . 2 . This
plasmid contains the following elements : (a), PvuII-Ncol fragment of tk
gene from herpes simplex virus (Bc1I-Clal portion of prKSVX-act 1) ; (b),
Pstl-BamHI fragment of pSV2neo (C1al-BamHI portion of the plasmid) ;
(c), BamHI-Bg1II fragment ofpSV2hph (BamHI-Bg1II portion ofthe plas-
mid) ; (d), Mstl-EcoRI fragment of ß'-actin cDNA (Bg1II-HindUI portion
oftheplasmid) ; (e), HindIII-ÁcclfragmentofpSV2neo (HindIII-M1ul por-
tion ofthe plasmid) ; (f), Accl-ApaLI fragment of pSV2neo (M1uI-ApaLI
portion of the plasmid) ; (g), ApaLI-ApaLI fragment of pUC19 (ApaLI-
ApaLI portion ofthe plasmid) ; and (h), ApaLI-EcoRI fragment of pSV2neo
(ApaLI-BclI portion of the plasmid) .
To construct truncated tk gene of herpes simplex virus, the segment
flanked by two MluI sites was removed through digesting the DNA with
M1ul, blunting theendsbythe Klenow fragment ofE. coliDNA polymerase
1, and ligating the blunted ends by T4 DNA ligase . This deletion leaves in-
tact the enhancer/promoter region but removes all of the wild type-
nontranslated leader and the first 10 codons for tk polypeptide .
DNA Tlransformation
Plasmids were transferred as supercoiled circularDNA using the calcium
phosphate precipitation procedure (Graham and van der Eb, 1973) . The
o-actin
￿
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final amount ofDNA added to a 25-cm2 flask was 10 hg . The medium was
changed 4 h before transfection . The precipitates in a final volume of 0.5
nil were added to 5 ml medium . After incubation for 16 h, the cells were
treated with 15% glycerol in Hepes-buffered saline (20mM Hepes, 137mM
NaCl, 2 .7 mM KCI, pH 7.5) for 3 min, and were then incubated for 20 h
inMEM . The cells were harvested by trypsin-EDTA treatment, counted,
and replaced at N2 x 1()6 cells per 100-mm dish inHAT medium (MEM
containing 100 pM hypoxanthine, 4 14M aminopterine, and 16 AM thymí-
dine) . The medium was changed every 4 d. On the 16th day after the addi-
tion ofHAT medium, the medium was replaced byHT medium(MEM con-
taining 100 AM hypoxanthine and 16 uM thymidine) containing 2 Wg/nil
of CB. After a further 5 d, the cells were fed again with MEM containing
CB at 2 tcg/ml, and continued to incubate for 5 d . Individual colonies were
isolated with cloning cylinders and propagated into mass culture.
Assayfor Cytochalasin Resistance
The resistance of cells to the growth-inhibitory effect of cytochalasin was
determined by plating 150 cells at various drug concentrations in 6-well
muldwell plate(Falcon 3046 ; Becton Dickinson and Co., Ltd., Tokyo) con-
taining 4 ml MEM . After 12 d of incubation at 37'C in a C02 incubator,
the cells were stained with 1% methylene blue in 50% ethanol . The resis-
tance is expressed by Dla value : the drug concentration that reduces cell
survival to 10% .
Southern BlotAnalysis
GenomicDNA was digested with 6U restriction endonucleaseper kg DNA
at37'C for 16h, andelectrophoresed in 0.7 % agarose (10,ugDNA per slot) .
The electrophoresed DNA fragments were transferred to nylon membranes
(Nytran-N ; Schleicher& Schuell, Inc ., Keene, NH) . The membranes were
hybridized with digoxigenin-labeled probes . Probes were prepared using
nonradioactive DNA labeling kit (Boehringer Mannheim GmbH) . Hybrid-
ization and washing were done according to the protocol in the kit. The hy-
bridizedprobes were detected with antidigoxigenin antibody : alkaline phos-
phatase conjugate (Boehringer Mannheim GmbH) and by soaking in the
luminescent substrate (Lumiphos 530; Lumigen, Inc., Detroit, MI) . The
filters were wrapped in Saranwrap and exposed to Fuji RX X-ray film (Fuji
Photo Film Co . Ltd ., Tokyo) .
IEFin Vertical SlabGel
IEF in 4 .5% acrylamide vertical slab gel was carried out as described previ-
ously (Toyama and Toyama, 1988), except that cathode electrode solution
was 20 mMNaOH and anode electrode solution was 10mM H 3PO4. Gels
were stained using silver stain kit Wako (Wako Pure Chemical Industries,
Ltd ., Osaka, Japan) . Lanes were scanned and the peaks were integrated
with a scanning densitometer (Biomed Instruments Inc., Fullerton, CA) .
Results
Defining theMutationon ß'ActinbyDNA Sequencing
We have previously reported that the isoelectric point of
TAC GCC AAC
TAC GAC AAC
TA
COOH
Figure 1. Locating and sequencing the Cyt I mutation . Schema of cDNA and polypeptide of ß'-actin are presented, and the nucleotide
sequence and predicted amino acid sequence surrounding mutation sites are presented . These sequence data are available from EMBL/
GenBank/DDBJ under accession number X63432 .ß'-actin is more acidic than that of ß-actin, by approximately
one electrical charge, and that this alteration is not the result
of a posttranslational modification (Toyama and Toyama,
1984) . These findings suggest that ß'-actin has a substitution
of amino acid involving a charged one . To prove this directly,
we isolated cDNA clones encoding f- and -1-actins from
Cyt 1 cells, and sequenced these cDNA clones . The coding
region of f-actin cDNA had nucleotide sequence identical
to that of a reported ,B-actin cDNA (Ponte et al ., 1984), ex-
cept for two base substitutions that alter the predicted amino
acid sequence (Fig. 1) . A firstand unexpected mutation was
found in colon 139, and this was a GC to AT transition(GTG
-~ ATG) to give an amino acid substitution of Va1139 -" Met .
A second mutation had a CG to AT transversion (GCC --"
GAC) at codon 295. This would replace Alaz 95 - Asp ; the
predicted gain of a positive charge accounts for the altered
isoelectric point of f-actin .
Thenucleotide sequence ofcoding region of-y-actincDNA
was identical to that of the y-actin gene from HeLa cells
(Erba et al ., 1988) .
StrategyfortheConstruction ofExpression Vector
To exclude the possibility that mutations in molecules other
than ß-actinmay account for theCB resistance ofCyt 1 cells,
it is necessary to express the ß'-actincDNA in cytochalasin-
sensitive parental KB cells. Since in vitro polymerization
studies have indicated that the resistance toCB is determined
by the relative amount ofß'-actin to ß-actin or of ß'-actin to
,y-actin (Toyama, S ., unpublished results), and since actin is
the most abundant protein in KB cells,we reasoned that high
level expression of the transfected f-actincDNA is required
for transformed cells to express cytochalasin-resistant phe-
notype . Therefore, we designed an expression vector for the
direct screening of transformed cells with high level expres-
sion . As a selectable gene, we chose truncated tkgene ofher-
pes simplex virus (see Materials and Methods) . This is based
on the property of Al deletion in tk gene. This deletion re-
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Figure 2 . Structure of pTKSVß'-act 1 . pTKSV
ß'-act 1 carries a 1.27-kb EcoRI-Mstl fragment from
ß'-actincDNA containingthe entire coding region
plus 87 nucleotides of 5'-noncoding sequence and
52 nucleotides of 3'-noncoding sequence. The
ß'-actin cDNA is under the control of SV40 en-
hancer/promoter combination and followed by the
SV40 splice and polyadenylation signal . Arrows
indicate the direction of transcription . Some re-
striction sites used for the construction and the fur-
ther analysis of the vector are indicated .
moves the first 27 codons of tk polypeptide, and conse-
quently, translation initiates from the second AUG colon
(Halpern and Smiley, 1984) . The Al produces -40% ofthe
tk protein synthesized by wild-type virus (Irmiere et al .,
1989) . After transfection of the expression vector carrying
the truncated tk gene into TK- cells, it is expected that only
such transformed cells that express high levels of tk polypep-
tide will survive HAT selection . Because there is some rela-
tion between expression level and copy number of gene, high
copynumber of the integrated expression vector could com-
pensate the reduced expression level of tk protein . Conse-
quently, these cells are expected to exhibit high expression
levels for the linked nonselected genes . Since the level of
expression is also determined by the strength of enhancer/
promoter activity, we tested various enhancer/promoter com-
binations from different sources (such as SV40, cytomega-
lovirus, and ,ß-actin) . Among the tested ones, SV40 enhanc-
er/promoter combination was the most efficient to express
ß'-actin cDNA on KB cells . Based on these considerations,
we have constructed the expression vector depicted in Fig . 2 .
Expression ofß'ActincDNA Confers Cytochalasin
Resistance upon Transformed Cells
KB100 TK- cells were transfected with ß'-actin expression
vectorpTKSVß'-act 1 . TK+ transformants were first selected
in HAT medium, and they were then incubated in medium
containing 2 ug/ml of CB . -35% of the TK+ transformants
survived the CB treatment . Eight individual clones were
picked and grown to mass culture (Tff-ll-Tff-18) . These
clones were tested for their ability to grow in the presence
of varying concentrations of CB, and the amount of ß'-actin
in these clones was quantitated from densitometric scan of
IEF gels . Fig . 3 shows anIEF pattern of proteins from these
transformant clones . All of the transformant clones displayed
aprotein band whichhad the same isoelectricpointas ß'-actin
of Cyt 1 cells, but the intensity of the bands varied amongFigure 3 . IEF analysis of extracts from KB cells transformed with
pTKSVß'-act 1 . Monolayers of cells were washed two times with
PBS . The cells wereharvested by scrapingwith a rubber policeman
and washed two times with PBS . The final pellets were dissolved
directly in O'Farrel's lysis buffer (O'Farrel, 1975) . The gels were
run as described in Materials and Methods . (Lane 1) KB100 TK- ;
(lane 2) Tfß'-11 ; (lane 3) Tfß'-12 ; (lane 4) Tfß'-13 ; (lane 5) Tfß'-
14 ; (lane 6) Tfß'-15 ; (lane 7) Tfß'-16 ; (lane 8) Tfß'-17 ; (lane 9)
TTß'48 ; and (lane 10) KB100 Cyt 1 .
different clones . As expected, expression of the ß'-actin
cDNA conferred cytochalasin resistance upon transformed
cells, and expression levels of ß'-actin correlated well with
levels of resistance to CB (Table I) . Essentially identical re-
sults were obtained, when TK+ transformants were selected
Table I . Relationship between Expression Levels ofß'-Actin and Levels ofCB Resistance
* Values were calculated from the j3-/,y-actin ratios of the transformed and wild-type TK- cells.
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inHAT medium and these clones were individually analyzed
without CB selection, except that -65% of the TK+ trans-
formants expressed relatively low amounts ofß'-actin (<5
ofthe total actin) and did not exhibit any increased resistance
to CB . No cytochalasin-resistant colonies appeared in con-
trol groups that were mock transfected, or transfected with
the expression vector containing either 'y-actin cDNA or
chimeric ß-actin cDNA (Fig. 4) . Transformant clones also
exhibited increased resistance to cytochalasins D and E (re-
sults not shown) .
To confirm further the relationship between the amount of
ß'-actin and the level of resistance to CB, we selected one
relatively unstable transformant clone (Tfß'-17) and serially
passaged it in the stepwise increasing concentration of CB
(3, 5, and 9 P,g/mI) . The cells termed Tfß'-17(9), were then
passaged for 40 times in the absence of CB [Tfß'-17(40)] .
Expression levels of ß'-actin and levels of CB resistance in
these cells were determined as described above . The results
are shown in Table 1 . The passage in CB led to the signifi-
cant increase in the amount of ß'-actin, which comprised
-40% of the total actin in Tfß'-17(9) cells . Concomitantly,
Tfß'-17(9) cells exhibited a D O for CB of 9.7 Ftg/ml, which
is only slightly lower than that of Cyt 1 cells (12 ttg/ml),
when Tfß'-17(9) cells had beenpassaged in the absence ofCB
[Tfß'-17(40)], the amount of ß'-actin was reduced to 10% of
the total actin . This decrease in the expression level of ß'-actin
paralleled decrease in the resistance level to CB (D,o, 1.9
p.g/ml) .
Mutation ofBoth Vah39-Metand Alaz95 -"Asp Is
Required to Produce Cytochalasin Resistance
Since the ß'-actin cDNA carries two mutations that lead two
amino acid substitutions, we ask whether both mutations are
required to produce cytochalasin resistance. To this end,
we constructedhybridcDNAs byexchange ofrestriction frag-
ments between ß'- and y-actin cDNA (Fig. 4) . Plasmid con-
taining these chimeric cDNA (pTKSVß'-act 2 and pTKSV
ß'-act 3) were transfected into KB100 TK- cells, and trans-
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Transfected
actin cDNA Strain Mutation
Fraction of 0'-actin
(% of total actin) Dio
lUg/ml
None TK- None 0 1.4
None Cyt 1 Val 139-Met, Ala'91-Asp 50 12.0
ß'-Actin 1 Tfß'-12 Val'39- Met, Alaz95-Asp 7 1 .5
ß'-Actin 1 Tfß'-16 Val' 39-Met, Alaz95-Asp 8 1 .6
ß'-Actin 1 Tfß'-14 Val"9-Met, Alaz95-Asp 24 2.0
ß'-Actin 1 Tfß'-15 Val'J9- Met, Alaz95-Asp 25 2.2
ß'-Actin 1 Tfß'-11 Val'N-"Met, Alaz95-Asp 27 2.2
ß'-Actin 1 Tfß'-13 Val' 39-Met, Alaz95-Asp 28 2.5
ß'-Actin 1 Tfß'-18 Val"9-Met, Alaz95-Asp 28 2.6
ß'-Actin 1 Tfß'-17 Val' 39-Met, Alaz95-Asp 32 3.2
ß'-Actin 1 Tfß'-17(9) Val ' 39-Met, Alaz95-Asp 41 9.7
ß'-Actin 1 Tfß'-17(40') Val' 39-Met, Alaz95-Asp 10 1 .9
ß'-Actin 2 Tfß'-21 Val"-Met 30* 1 .8
ß'-Actin 2 Tfß'-22 Val139-Met 24* 1 .7
ß'-Actin 3 Tfß'-31 Alaz95-Asp 20 1 .6
ß'-Actin 3 Tfß'-32 Alaz95-Asp 34 1 .8Nco I
￿
Nar
￿
Ost Ell
l
￿
I
ßt .-actin 1
￿
I
5 °
ÁTG
￿
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0=actin 2
￿
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X-actin3
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￿
GTG
￿
GCC TAA
Figure 4 . Construction of restriction fragment chimeras . Restriction fragment chimeras were constructed by exchange of restriction frag-
ment between 0'-actin and -y-actin cDNAs . To create the unique Ncol site at the same position as in the ß'-actin cDNA, guanine at 1
nucleotide upstream from the initiatorATG codon ofy-actincDNA was replaced by cytosine (by site-directed mutagenesis) . The restriction
sites that can be used for the construction of chimeras are indicated .
formants were selected as described in the preceding section .
The transformants thus obtained were tested for their ability
to grow in the presence of varying amounts of CB and the
amount of mutant actin in these transformants was deter-
mined by scanning IEF gels . The expression ofcDNA carry-
ing mutation Alaz95 - Asp (ß'-actin 3) produced a polypep-
tide that migrated to the same position as ß'-actin, whereas
the expression of cDNA carrying mutation Val'39 - Met
(ß'-actin 2) produced a polypeptide that could not be sep-
arated from ß-actin (Fig. 5) . This provides direct evidence
that mutation Alaz95 - Asp is responsible for the altered
isoelectric point ofß'-actin . The expression ofcDNA carry-
ing either of two single substitutions (Alaz95- Asp or Val' 39
- Met) conferred a low level of resistance to CB (Table I) .
The expression levels of mutant actin in transformants con-
taining Alaz95 - Asp substitution were comparable to those
containing both Alaz95- Asp and Va1139 -> Met substitutions
(Table I) . The transformants expressing Vá1139- Met muta-
tion did exhibit an increase in the ß-/-y-actin ratio . Based on
the comparison of ß-/-y-actin ratio between the transformed
and wild-type KB cells, we infer that the expression levels
of mutant actin in these transformants are comparable to
those in transformants containing Alaz95 -> Asp substitution
(Table I) .
These results indicate that mutation of both Val'" - Met
and Alaz 95 - Asp is required to produce a CB-resistant
phenotype of Cyt 1 cells . Substitution ofeither one of these
residues results in a low level of CB resistance .
Southern Blot Analysis ofIntegrated
Plasmid Sequences
To exclude the little possibility that the cytochalasin-resistant
phenotype oftransformants is due to the integration ofvector
DNA into specific site ofTK- cell genome (i.e ., insertional
mutation of a special gene that determines sensitivity to cy-
tochalasin), chromosomal DNAs from six transformant
clones were digested with the enzyme BamHI, which cuts
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the pTKSVß'-act 1 sequence at a unique site, transferred to
a nylonmembrane after electrophoresis on agarose gel, and
probed for a tk gene sequence (Fig . 6 A) . DNA from five
clones [Tfß'-19, Tfß'-110, Tfß'-111, Tfß'-112, and TTß'-17(9)]
yielded a prominent 6.58-kb fragment that was the size of in-
tact linear pTKSVß'-act 1 plasmid . Minor bands were also
visible on the blot . These bands most probably correspond
to DNA fragments containing the joining site between plas-
mid and cellularDNA . Each cell clone yielded a specific pat-
tern of joining fragments . Similar results were obtained
when a ß'-actin probe was used instead of the tk probe, except
that several additional weak signals which derived from en-
dogenous actin-related genes were observed (Fig . 6 B) . Re-
striction enzymes which do not cut out the pTKSVß'-act 1
sequence produced fragments of more than 23 kb in size
(data not shown) . An exception is clone Tfß'-113 . This clone,
which did not reveal any hybridization signal, no longer ex-
hibited cytochalasin resistance and failed to show the ß'-actin
polypeptide on IEF gels (data not shown), suggesting that the
transfected plasmid sequence had been lost during the pro-
cess of cloning .
These results clearly show that the plasmid pTKSVß'-act 1
sequence is integrated in various sites of the chromosomal
DNA as tandemly arranged intact units . As expected, these
results also suggest that the high level expression of ß'-actin
is correlated with high copynumber of the integrated expres-
sion vector.
CB-induced CellularResponses in Ransformed Cells
To show further that the effect of CB on cell motility pro-
cesses is through actin, we have analyzed some CB-induced
cellular responses in transformed Tfß'-17(9) cells .
Untreated KB100 TK- cells displayed prominent array of
stress fiber (Fig. 7 A) . The expression of ß'-actin in these
cells caused reorganization of actin filaments . In Tfß'-17(9)
cells, the filaments became thinner in width and shorter in
length . They intersected with each other (Fig . 7 C) . This or-Figure S IEF analysis of extracts from KB cells transformed with
pTKSVO'-act 2 and pTKSVO'-act 3. Lysates were prepared from
transformants expressing Val' 39 ~ Met mutation (Tfß'-21 and Tf
0'-22) and Ala2°5 - Asp mutation (Tfß'-31 and Tfß'-32) as de-
scribed in the legend to Fig. 3 . (Lane 1) KB100 TK- ; (lane 2) Tf
/3'-21 ; (lane 3) Tfß'-22 ; (lane 4) Tfß'-31 ; (lane 5) Tfß'-32 ; and
(lane 6) KB100 Cyt 1 .
ganization of actin filaments was close to that of Cyt 1 cells
(Fig. 7 E) . Exposure ofKB100 TK- cells with CB resulted
in a disruption of actin filament bundles and most ofthe poly-
merized actin was gathered into aggregates of varying size
(Fig . 7 B) . In contrast, treatment of Tfß'-17(9) and Cyt 1
cells with CB resulted in little alteration in the distribution
of actin filaments (Fig. 7, D and F) .
The projection ofknobby protuberance at cell surface (zei-
osis) is a general cellular response to CB . WhenKB100 cells
were treated with 20 IiM CB, the cell surface was beset by
the cluster of zeiotic knobs within 10 min (Fig . 8, A and B) .
In contrast, the cell surface ofTfß'-17(9) and Cyt 1 cells ap-
peared to remain unchanged in the presence ofCB (Fig . 8,
C-F) .
Discussion
Our goal was to prove that the mutation in 0-actin is solely
responsible for the cytochalasin-resistantphenotype of Cyt 1
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Figure 6. Southern blot analysis of independent pTKSVO'-act 1
transformants . High molecular weightDNA from the transformant
cells were digested with BamHI, submitted to electrophoresis in
0.7% agarose, transferred to a nylon membrane, and hybridized to
a 1.57-kb ClaI-Bc1I fragment (tk probe) from pTKSVO'-act I (A) .
The membrane was stripped off the hybridized tk probe and
reprobed with a 1.18-kb NcoI-Bg1II fragment (ß'-actin probe) from
pTKSVO'-act 1 (B) . The size of standardDNA is indicated in kilo-
base pairs . (Lanes 1) pTKSVO'-act 1 cleaved withBamRI (10.4 pg :
approximating single-copy gene present in the amount of DNA
loaded to gel) ; (lane 2) KB100 TK- ; (lanes 3) Tfß'-19 ; (lanes 4)
Tfß'-110 ; (lanes 5) Tfß'-111 ; (lane 6) Tfß'-112 ; (lanes 7) Tfß'-113 ;
and (lanes 8) Tfß'-17(9) .
cells . We have isolated and sequenced the cDNA encoding
cytochalasin-resistant ß'-actin . The ß'-actin cDNA was sub-
cloned into expression vector and expressed in cytochalasin-
sensitive parental KB cells . Sequence analysis ofthe ß'-actin
cDNA reveals the presence of two amino acid substitutions
(Vá1'39 -" Met and Ala 295- Asp) . Expression of the ß'-actin
cDNA in wild-typeKB cells results in the synthesis ofß'-actin
and confers cytochalasin resistance. Levels of resistance to
CB in transformed cells correlate well withamounts ofß'-actin
polypeptides . Based on these results together with our previ-
ous finding that ß'-actin is more resistant than ß- or -y-actin
to the multiple effects of CB (Toyama and Toyama, 1988),
we conclude that the primary site of action ofCB on cellmo-
tility processes is actin .
Interestingly, our results obtained by transfection experi-
ments with chimeric actin cDNA clearly demonstrate that
mutation of both Val'39 -" Met and Ala295 - Asp is required
for high level expression of cytochalasin resistance in trans-
formed cells. This suggests that residues Val' 39 and Ala295
are located in or close to a region which is involved in the
binding ofcytochalasins, since our previous work has shown
that purified ß'-actin displays a decreased binding affinity for
CB (Toyama and Toyama, 1988) . Very recently, the structure
ofthe actin-DNase I complex has been solved at 2 .8 A reso-
lution by X-ray crystallography and an atomic model for
F actin has also been proposed (Kabsch et al ., 1990 ; Holmes
et al ., 1990) . According to the atomic model of actin, Val'39
is located in the a-helix (residues 137-144) of subdomain 1
and Ala295 is located adjacent to the short helix (residues
288-294) in the subdomain 3. Residues Vá1' 39 and Ala295
stand at opposite sides ofthe cleft between subdomains 1 and
3 . The logical consequence of these considerations is that cy-
938Figure 7 . Fluorescence micrographs of actin filaments in CB-treated cells . Cells were treated with 20 /,M CB for 60 min at 37°C . They
were then fixed and stained with rhodamine-phalloidin as described previously (Toyama and Toyama, 1988) . (A) Untreated KB100 TK-
cells ; (B) CB-treated KB100 TK- cells ; (C) untreated Tfß'-17(9) cells ; (D) CB-treated Tfß'-17(9) cells; (E) untreated KB100 Cyt 1 cells ;
and (F) CB-treated KB100 Cyt 1 cells. Bar, 20 jtm .
tochalasin is bound near the base of the cleft between sub-
domains 1 and 3. Based on this interpretation, together with
our previous finding that the CB binding site onmonomeric
actin is structurally correlated with the high affinity binding
site on filamentous actin (Toyama and Toyama, 1988), we
propose that the cytochalasin-binding site on monomeric and
filamentous actin is the same but its binding affinity for cyto-
chalasin is determined by the conformation about the cleft .
Polymerization of monomeric actin to the barbed end of fila-
mentous actin results in a conformational change about the
cleft to a state where cytochalasin is bound more tightly. The
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predicted cytochalasin binding site is located near the hinge
which links the small and large domain atthe base ofthe cleft .
Thebinding ofcytochalasins could result in a conformational
change about the hinge, leading to a change in the relative
orientation ofthe two domains. This model provides the struc-
tural basis to explain multiple effects of cytochalasins to ac-
tin . The present study represents the first step to investigate
the molecular dynamics of actin-cytochalasin interaction .
Our previous studies have shown that the increased resis-
tance to CB of Cyt 1 cells is reflected in reduced affinity for
the binding ofCB by ß'-actin (Toyama and Toyama, 1988) .
939Figure 8 . Effect ofCB on cell morphology . Cells were incubated at 37°C for 7 min in the presence of 20 pM CB and then examined by
phase-contrast microscopy. (A) Untreated KB100 TK- cells ; (B) CB-treated KB100 TK- cells ; (C) untreated Tfß'-17(9) cells ; (D) CB-
treated TFß'-17(9) cells ; (E) untreated KB100 Cyt 1 cells ; and (F) CB-treated KB100 Cyt 1 cells . Bar, 50 km .
However, since -y-actin is still present in the Cyt 1 cells, it
is difficult to reconcile the reduced CB-binding affinity of
ß'-actin as the mechanism of resistance with the general be-
lief that CB inhibits actin polymerization by capping the
barbed end of actin filaments (Lin et al ., 1980 ; MacLean-
Fletcher and Pollard, 1980 ; Brown and Spudich, 1981 ; Pol-
lard and Mooseker, 1981 ; Mabuchi, 1983 ; Bonder and Moose-
ker, 1986) ; i .e ., if ß'-actin at the barbed end of actin filament
has reduced ability to bind CB, the further addition ofy-actin
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to this terminal ß'-actin should restore the ability ofthe actin
filament to bind the drug . To solve this conflict, we proposed
that ß- and y-actin are functionally interchangeable and,
consequently, the sensitivity of cells toCB is determined by
the relative amount of ß'-actin to y-actin . This explanation
is substantiated by our present finding that the level of cyto-
chalasin resistance in cells transformed with ß'-actin cDNA
is determined by the relative amount of exogenous ß'-actin
to endogenous ß- and y-actins (i .e ., incomplete dominance) .
940Further support for the functional interchangeability between
ß- and y-actin is provided by the observation that the 7-actin
cDNA carrying two mutations (Valt39 - Met and Ala291
Asp) confers cytochalasin resistance upon transformed KB
cells (Ohmori, H., and S. Toyama, unpublished results).
It has heretofore not been possible to unambiguously dem-
onstrate differences in the function associated with given ac-
tin isoforms in vivo. This is largely because of the lack of
direct methods to examine the functional capacity of differ-
ent actin isoforms. Gene transfer method with actin isoform
cDNA carrying cytochalasin-resistant mutation can be used
to solve this difficulty; ifmore cytochalasin is required to in-
hibit a process in the transformed cells that express cyto-
chalasin-resistant actin isoform than is required in control
cells, one may be reasonably confident that the newly intro-
duced actin isoform could be involved in the process. Gene
transfer experiments described above with -y-actin cDNA
carrying two mutations present a model example of this kind
of analysis.
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